Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how American Bio Medica Corporation turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $913,000 | $2.22M | $4.15M | $3.65M | $3.87M | $4.91M | $5.61M | $6.32M | $7.29M | $8.89M |
| Revenue Growth? | -58.8% | -46.5% | +13.5% | -5.6% | -21.2% | -12.4% | -11.2% | -13.3% | -18.1% | 0.0% |
| Cost of Revenue? | $1.11M | $1.67M | $2.91M | $2.47M | $2.58M | $2.92M | $3.12M | $3.46M | $4.22M | $5.32M |
| Gross Profit? | -$193,000 | $548,000 | $1.24M | $1.18M | $1.29M | $2.00M | $2.49M | $2.85M | $3.06M | $3.57M |
| Gross Margin? | -21.1% | +24.7% | +29.9% | +32.4% | +33.3% | +40.6% | +44.4% | +45.2% | +42.0% | +40.2% |
| Operating Expenses? | $1.05M | $1.73M | $1.86M | $1.78M | $2.05M | $2.31M | $2.75M | $3.08M | $3.28M | $4.70M |
| Operating Income? | -$1.24M | -$1.18M | -$621,000 | -$593,000 | -$762,000 | -$311,000 | -$257,000 | -$226,000 | -$217,000 | -$1.13M |
| EBITDA? | -$1.16M | -$199,000 | -$540,000 | -$340,000 | -$661,000 | -$193,000 | $34,000 | $180,000 | -$133,000 | -$360,000 |
| Income Before Tax | -$1.41M | -$461,000 | -$794,000 | -$686,000 | -$1.03M | -$545,000 | -$341,000 | -$331,000 | -$488,000 | -$786,000 |
| Income Tax Expense | $2,000 | $2,000 | $2,000 | -$5,000 | $2,000 | $0 | $4,000 | $2,000 | $2,000 | $2,000 |
| Net Income? | -$1.41M | -$463,000 | -$796,000 | -$681,000 | -$1.03M | -$545,000 | -$345,000 | -$333,000 | -$490,000 | -$788,000 |
| EPS? | $-0.03 | $-0.01 | $-0.02 | $-0.02 | $-0.03 | $-0.02 | $-0.01 | $-0.01 | $-0.02 | $-0.04 |
| Diluted EPS? | $-0.03 | $-0.01 | $-0.02 | $-0.02 | $-0.03 | $-0.02 | $-0.01 | $-0.01 | $-0.02 | $-0.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality